Job Description
Associate Director, Market Access Strategy - T1D
Location: Boston, MA (3 days onsite, 2 days remote weekly)
General Summary:
Vertex currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in Pain, Type 1 diabetes, IgA Nephropathy (IgAN), APOL-1 Mediated Kidney Disease, and Duchenne Muscular Dystrophy, among others.
The Associate Director, Market Access Strategy – T1D (VX-880) will be responsible for delivering impactful market access strategies and resources to maximize access and uptake for the commercialization of the T1D program, currently in late -stage development. This role will work closely with Brand Marketing, Medical Affairs, Public Affairs, HEOR, Payer Account Management, and Field colleagues to ensure goal alignment and to meet corporate objectives. This position will report into the Senior Director, Market Access Strategy - T1D.
Key Duties and Responsibilities:
-
Develop US market access strategies and tactical plans to support the upcoming T1D program, flawlessly executing key Payer, hospital and Trade initiatives to secure rapid and broad access
-
Lead initiatives to understand, analyze and demonstrate the clinical, economic and societal value to payers, hospitals, decision-makers and influencers; collaborate with GIACO to plan and implement market research
-
Co-create resources to support field pull-through engagement with HCPs
-
Assist in the design and build out of the value story across payer and trade channels
-
Lead capability building and thought leadership projects that advance knowledge of and readiness for the rapidly evolving payer environment
-
Support the Market Access Field Organization in customer segmentation strategy, planning and execution (eg training, account management tools/resources, and POA needs)
-
Manage day-to-day agency and vendor workflow to ensure resources are delivered on time & w/in budget
-
Instrumental in brand planning activities; plan and execute Payer/Trade ad boards
-
Accountable for CRM requirements and insight mining, CRC reviews, Customer Facing Talking points and establishment of launch KPIs
-
Define and establish Trade resources in tandem with Trade field leadership
-
Act as trusted, subject matter expert on US payer landscape to internal colleagues and externally facing customers
Knowledge and Skills:
-
Knowledge of US payer coverage, hospital reimbursement and CMS policies; hospital or CGT experience a plus
-
Ability to translate clinical data into economic messages
-
Marketing or other relevant strategic planning and execution skills including: positioning, branding, project management, and working collaboratively with agencies and vendors – recent Managed markets experience preferred
-
Ability to perform in a fast-paced environment, manage multiple priorities simultaneously, and work effectively across cross-functional teams
-
Proven track record of meeting or exceeding objectives & goals, both as an individual and as part of a team
-
Excellent communication skills with experience presenting to customers and internal leadership
-
US Product launch experience a must
Education and Experience:
-
Bachelor’s degree in relevant field
-
Typically requires 8+ years of MA experience or the equivalent combination of education and experience
#LI-KM3
#LI-Hybrid
Flex Designation:
Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
What We Do
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development.
Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.